enrofloxacin has been researched along with Dysentery, Bacillary in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herrod, JA; Hutchinson, EK; Maxwell, AR | 1 |
| Handt, L; Hasselschwert, D; Kastello, M; Klein, H | 1 |
| Banish, LD; Bush, M; Montali, RJ; Sack, D; Sims, R | 1 |
| Black-Schultz, L; Coatney, RW; Swif, B; Warnick, CL | 1 |
| Aucoin, DP; Hirsh, DC; Line, AS; Paul-Murphy, J | 1 |
1 trial(s) available for enrofloxacin and Dysentery, Bacillary
| Article | Year |
|---|---|
A comparison of different antibiotic regimens for the treatment of naturally acquired shigellosis in rhesus and pigtailed macaques (Macaca mulatta and nemestrina).
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Dysentery, Bacillary; Enrofloxacin; Macaca mulatta; Macaca nemestrina; Shigella | 2022 |
4 other study(ies) available for enrofloxacin and Dysentery, Bacillary
| Article | Year |
|---|---|
A pharmacokinetic study of enrofloxacin and its active metabolite ciprofloxacin after oral and intramuscular dosing of enrofloxacin in rhesus monkeys (Macaca mulatta).
Topics: Administration, Oral; Animals; Anti-Infective Agents; Chromatography; Ciprofloxacin; Cross-Over Studies; Drinking; Dysentery, Bacillary; Enrofloxacin; Female; Fluoroquinolones; Injections, Intramuscular; Macaca mulatta; Male; Shigella flexneri; Solid Phase Extraction; Tandem Mass Spectrometry | 2008 |
Clearance of Shigella flexneri carriers in a zoologic collection of primates.
Topics: Animals; Animals, Zoo; Anti-Infective Agents; Carrier State; Disinfection; District of Columbia; Drug Resistance, Microbial; Dysentery, Bacillary; Enrofloxacin; Feces; Female; Fluoroquinolones; Housing, Animal; Male; Monkey Diseases; Primates; Quinolones; Shigella flexneri; Shigella sonnei; Treatment Outcome | 1993 |
Lack of reactivation of shigellosis in naturally infected enrofloxacin-treated cynomolgus monkeys after exogenous immunosuppression.
Topics: Animals; Anti-Infective Agents; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Dysentery, Bacillary; Enrofloxacin; Feces; Female; Fluoroquinolones; Immune System; Immunosuppressive Agents; Lymphocyte Activation; Macaca fascicularis; Male; Methylprednisolone; Monkey Diseases; Phytohemagglutinins; Quinolones; Shigella flexneri; Tritium | 1997 |
Enrofloxacin treatment of long-tailed macaques with acute bacillary dysentery due to multiresistant Shigella flexneri IV.
Topics: Animals; Animals, Laboratory; Anti-Infective Agents; Disease Outbreaks; Drug Resistance, Microbial; Dysentery, Bacillary; Enrofloxacin; Female; Fluoroquinolones; Macaca; Monkey Diseases; Quinolones; Shigella flexneri | 1992 |